Showing results (61-70 of 251) with videos related to

Sort By:
Pageof 26
Radiation Oncology (London, England)|March 18, 2021
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalitiesHaruki Kobayashi, Kazushige Wakuda, Tateaki Naito, et al.
Investigational New Drugs|June 12, 2019
Negative impact of malignant effusion on osimertinib treatment for non-small cell lung cancer harboring EGFR mutationTakahisa Kawamura, Hirotsugu Kenmotsu, Haruki Kobayashi, et al.
Clinical Lung Cancer|April 2, 2013
Dose-escalation study of three-dimensional conformal thoracic radiotherapy with concurrent S-1 and cisplatin for inoperable stage III non-small-cell lung cancerHideyuki Harada, Makoto Nishio, Haruyasu Murakami, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 29, 2010
Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysisKyoichi Kaira, Yoshiki Horie, Eriko Ayabe, et al.
Anticancer Research|December 27, 2011
Continuous administration of EGFR-TKIs following radiotherapy after disease progression in bone lesions for non-small cell lung cancerMinehiko Inomata, Takehito Shukuya, Toshiaki Takahashi, et al.
Lung Cancer (Amsterdam, Netherlands)|May 5, 2009
Efficacy of chemotherapy with carboplatin and paclitaxel for unresectable thymic carcinomaSatoshi Igawa, Haruyasu Murakami, Toshiaki Takahashi, et al.
Respiratory Investigation|May 24, 2014
Toxicity and efficacy of chemotherapy for non-small cell lung cancer with cavitary lesionsTakaaki Tokito, Takehito Shukuya, Hiroaki Akamatsu, et al.
Japanese Journal of Clinical Oncology|March 27, 2020
PD-L1 expression and response to pembrolizumab in patients with EGFR-mutant non-small cell lung cancerEriko Miyawaki, Haruyasu Murakami, Keita Mori, et al.
International Journal of Clinical Oncology|December 8, 2009
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancerHideyuki Harada, Nobuyuki Yamamoto, Toshiaki Takahashi, et al.
Japanese Journal of Clinical Oncology|December 11, 2012
Chemoradiotherapy for limited-disease small-cell lung cancer in elderly patients aged 75 years or olderTakehito Shukuya, Toshiaki Takahashi, Hideyuki Harada, et al.
Pageof 26